Yuki Han

Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents

So Takata, Genju Koh, Yuki Han et al. · Journal of Infection and Chemotherapy · 2018 · 55 citations · Full text

Pulmonary Tuberculosis, Cancer Immunosurveillance, Medicine +14

Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study

Tomonori Hirashima, Yoshitaka Tamura, Yuki Han et al. · BMC Cancer · 2018 · 36 citations · Full text

Rapid serodiagnosis of human mycobacteriosis by ELISA using cord factor (trehalose-6,6â²-dimyclate) purified from<i>Mycobacterium tuberculosis</i>as antigen

Hua He, Shiro Oka, Yuki Han et al. · FEMS Microbiology Letters · 1991 · 34 citations · Full text

Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19

Shoji Hashimoto, Kazuyuki Yoshizaki, Kazuko Uno et al. · Frontiers in Medicine · 2021 · 17 citations · Full text

Enzyme-linked immunosorbent assay (ELISA) using a glycolipid antigen for the serodiagnosis of melioidosis

Le Van Phung, Yuki Han, Shiro Oka et al. · FEMS Immunology & Medical Microbiology · 1995 · 11 citations

Diagnostic Mycology, Immunocytochemical Technique, Immunology +16